VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Sanofi vs Visa Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Sanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Visa Inc.
V · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Visa Inc. leads (77 / 100 vs 74 / 100 for Sanofi).
- Segment focus: Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)); Visa Inc. has 4 segments (35.9% in Data processing revenue).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs n/a.
- Moat breadth: Sanofi has 5 moat types across 3 domains; Visa Inc. has 7 across 4.
Primary market context
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Visa Inc.
Data processing revenue
Payment transaction processing (authorization, clearing and settlement) for VisaNet and related network access
Global
Issuers, acquirers, payment processors
Network processor / switch (authorization, clearing, settlement)
35.9%
Side-by-side metrics
Moat coverage
Shared moat types
Sanofi strengths
Visa Inc. strengths
Segment mix
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Visa Inc. segments
Full profile >Service revenue
Oligopoly
Data processing revenue
Oligopoly
International transaction revenue
Oligopoly
Other revenue
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.